Hôpitaux INCOMPATIBILITY Universitaires OF IV …–Drug incompatibility charts –Bedside teaching...
Transcript of Hôpitaux INCOMPATIBILITY Universitaires OF IV …–Drug incompatibility charts –Bedside teaching...
Etre les premiers pour vous
HôpitauxUniversitairesde Genève
INCOMPATIBILITY
OF IV DRUGS :
SOME CLINICAL
HIGHLIGHTS
Dre Caroline Fonzo-Christe
Pharmacie des HUG
2
FACULTY DISCLOSURE
No, nothing to disclose
x Yes, please specify:
Company NameHonoraria/
Expenses
Consulting/
Advisory
Board
Funded
Research
Royalties/
Patent
Stock
Options
Ownership
/ Equity
Position
EmployeeOther
(please specify)
Doran InternationalInvited
speaker
Pall companyInvited
speaker
3
WHAT ARE WE TALKING ABOUT?
Addition of midazolam
4
WHAT ARE WE TALKING ABOUT?
Addition of midazolam
WHAT ARE WE TALKING ABOUT?
B.Braun, KIK 2.1 2002 and Drug incompatibility 2011 www.safeinfusiontherapy.com
5
HUG
caspofungine + heparine
5
6
SOME QUESTIONS
• A theoretical problem?
• An old stuff?
• What are the clinical consequences?
• A pharmacist issue?
• What can we do? Can YOU do something
for this issue?
7
CONTEXT
Environment
• Temperature
• Light
Material
• PVC (DEHP)
• Silicone
•…
Drug A
Solvent +
excipients
Drug B
Factors
• Concentration
• Contact time
Solvent +
excipients
8
TYPE OF REACTIONS
Physico- chemical
• Acid-base reactions (pH)
• Solubility
• Emulsion cracking
• Oxydo-reduction
• …
Consequences
• Precipitates (visible)
• Colour change (visible)
• Gaz production (visible)
• pH change (invisible)
• concentration (invisible)
• Catheter occlusion
• Renal and pulmonary embolism
• therapeutic effect
• Toxic effects (peroxides) patient
9
ACIDS AND BASES
From: KIK 2.1,
BBraun, 2002
Acid drug molecule basic drug solution
Basic drug molecule acidic drug solution
Don’t mix or infuse
on Y-site
acidic with basic
drug solutions!
Molecule Drug
solution
Molecule Drug
solution
Furosemide (acid) pH 9 Furosemide (acid) pH 9
Vancomycin (base) pH 3 Midazolam (base) pH 4
From: KIK 2.1, BBraun, 2002
10
SOLVENT (DILUENT)
Furosemide in Glucose 5% From: KIK 2.1, BBraun, 2002
Glucose 5%-20% pH = 3.5 - 6.5 amiodarone, amphotericine B
NaCl 0.9% pH = 5.0 - 7.0 aciclovir, phenytoin
Solvent pH Appropriate for
11
LIPID EMULSION
reversible
irreversible
Coalescence :
pH
conc. AA
Electrolytes with
high valence (Ca2+,
Mg2+, PO43-)
Lipid emulsion is
not water!
11
SOLUBILITY
“Pastis effect”
drug excipient
amiodarone Cordarone® polysorbate (tween)
paracetamol Perfalgan® mannitol, phosphate, NaOH
esomeprazole Nexium® NaOH, EDTA
phenytoin Phenhydan® glycofurol-75, EDTA
clonazepam Rivotril® propylene glycol, acetic acid
Co-solvent and/or adjusting pH
can increase the solubility of
drugs in solution
13
CLINICAL INCIDENTS
Knowles JB et al. JPEN 1989;13:209-13
Hill SE et al. JPEN 1996;20:81-87 McNearney T et al. Dig Dis Sci 2003;48:1352-4
14
CALCIUM COMPLEXATION
Insoluble
Ceftriaxone – Calcium
Complex
Bradley JS et al. Pediatrics 2009;123:609-13
15
RECENT DATA: DRUG - DRUG
Kalikstad B et al. Arch Dis Child 2010;95:745-748
Zhao B et al. Am J Health-Syst Pharm 2014;71:901-902
Lack of DATA
in NICU
Case-reports of
catheter
occlusion
16
RECENT DATA: DRUG - SOLVENT
Christensen RD et al. Arch Dis Child Fetal Neonatal 2012;97:F3
Stark MJ et al. Arch Dis Child Fetal Neonatal 2012;97:F62-64
Blood always
alone
SOME QUESTIONS
• A theoretical problem?
• An old stuff?
• What are the clinical
consequences?
• Not only, also a real one
• Yes, well known problem
since the eighties, but still
a current problem in the
practice
• May lead to precipitates
and renal and pulmonaryembolism
17
18
AIR POLLUTION
Visible range:
> 50 m
Erythrocytes:
about 7.5 m
Capillary:
8-10 m
Brook RD. Clinical Science 2008;115:175–187
19
CLINICAL CONSEQUENCES
Mechanical local
endothelial
damage
Thrombotic and
inflammatory
response
Brook RD. Clinical Science 2008;115:175–187
S.I.R.S
Predisposition
to SIRS?
20
IN-LINE FILTRATION AND SIRS
Jack T et al. Intensive Care Med 2012;38:1008–1016
21
COSTS
Jack T. et al Intensive Care Med 2012;38:1008–1016
22
IN PRACTICE
Austr Prescr 2008;31:98-101
23
IN VITRO TESTING
Bouchoud L et al. JPEN J Parenter Enteral Nutr. 2013;37:416-24
24
TPN: CALCIUM/PHOSPHATE
Bouchoud L et al. JPEN J Parenter Enteral Nutr. 2010;4:542-5
• Phocytan ® (Glucose-1-phosphate Na)
• Glycophos ® (Glycerophosphate Na)
25
TOOLS
http://pharmacie.hug-ge.ch/infomedic/utilismedic/HUG_CompatAdm_DCI.pdf
26
I-TOOLS, DATA-BASES
http://fr.appbrain.com/app/injectable-medicines/air.coim, http://www.ahfsdruginformation.com,
http://www.theriaque.org, http://www.kik-service.de, http://www.stabilis.org, https://www.kingguide.com
27
HUG: IN-LINE FILTERS
http://pharmacie.hug-ge.ch/infomedic/utilismedic/filtres_USI.pdf
28
CHRU LILLE (FRANCE)
Foinard A et al. Anesth Analg 2013;116:101-6
Perez M. CHRU Lille
SOME QUESTIONS
• A pharmacist issue?
• What can we do? Can
YOU do something for this
issue?
• Yes, it is– In vitro testing
– Drug incompatibility charts
– Bedside teaching
But also…• Multidisciplinary team
working– Infusion material: In-line
filters, new devices
– Clinical pharmacist
physician
pharmacist
nurse
biomedical,
technicians…
29
ARE YOU READY TO INVEST?
Thank you
for your
attention